Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Auvinen P et al. |
Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions:correlation and colocalization with hyaluronan.
|
|
2 |
Bergh J., Kataja V. . |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up prostate cancer.
|
|
3 |
Hartikainen JM et al. |
An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found.
|
|
4 |
Herrstedt J et al. |
ESMO Minium Clinical Recommendations for prophylaxis of chemotheapy-induced nausea and vomitting.
|
|
5 |
Huddart R.A, Kataja V. |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of testicular seminoma.
|
|
6 |
Johansson R. |
Adverse effects of antineoplastic drugs .
|
|
7 |
Kataja V. |
Book reviews: Neal AJ, Hoskin PJ: Clinical Oncology - Basic Principles and Practice. 3rd edition.
|
|
8 |
Kataja V. |
Solunsalpaajahoito rintasyövän eri vaiheissa.
|
|
9 |
Kataja V et al. |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic brast cancer (MBC).
|
|
10 |
Koskela AK et al. |
Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis?
|
|
11 |
Metsola K et al. |
XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in the Finnish case-control study.
|
|
12 |
Mustonen P et al. |
Recurrences after immediate reconstruction in breast cancer.
|
|
13 |
Pavlidis N, Kataja V. |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of invasive bladder cancer.
|
|
14 |
Pirinen R et al. |
Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.
|
|
15 |
Pivot X et al. |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of squamous cell carcinoma of the head and neck.
|
|
16 |
Sillanpää P et al. |
NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
|
|
17 |
Sillanpää P et al. |
Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.
|
|
18 |
Stahl M et al. |
ESMO Minimal Clinical Recommendations for diagnosis,treatment and follow-up of esophageal cancer.
|
|
19 |
Tveit K. M, Kataja V. |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of rectal cancer.
|
|
20 |
Van Custem E.J.D. et al. |
ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of advanced colorectal cancer.
|
|
21 |
Van Cutsem E.J.D, Kataja V. |
ESMO Minium Clinical Recommendations for diagnosis,adjuvant treatment and follow-up of colon cancer.
|